Home » Topics » Disease categories and therapies » Immune

Immune
RSS

HHS announces contracts to develop MVA-based smallpox vaccines

Feb. 28, 2003

Dukoral approved in Canada

Feb. 27, 2003

GlaxoSmithKline develops new meningitis vaccine for Africa

Feb. 26, 2003

Active Biotech presents new immunomodulators targeting the CD80/CD28 interaction

Feb. 25, 2003

DOR BioPharma to license intranasal vaccine technology from U.K.'s Ministry of Defence

Feb. 21, 2003

Superior survival compared to Atgam not achieved in GvHD patients treated with ABX-CBL

Feb. 19, 2003

Development of oral botulinum toxin vaccine commences at DOR BioPharma

Feb. 19, 2003

PNA CXCR3 antisense lengthens skin allograft survival in vivo

Feb. 18, 2003

Histone deacetylase inhibitors block T-cell activity and may prevent allograft rejection

Feb. 18, 2003

IkB kinase 2: a potential target for prevention of transplant rejection

Feb. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...